Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Tuberculosis Clinical Diagnostics Research Consortium (TB CDRC)
Street 1: Johns Hopkins University School of Medicine; Center for TB Research and Boston Medical Center/Boston University
Street 2:
City: Baltimore
Province: MD
Post Code: 21231
Country: United States of America
Phone: 617-414-5277
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr.
First Name: Jerrold
Last Name: Ellner
Title: Principal Investigator

Alternate Focal Point Contact Information

Salutation: Dr.
First Name: Susan
Last Name: Dorman
Title: Co-Principal Investigator

General Information

Board Constituency: Technical agencies
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Academic / Research Institution
Organization Type - Secondary: None
Organization Description:
The Tuberculosis Clinical Diagnostics Research Consortium (TB CDRC) was established September 30, 2009 by the award of a contract to Johns Hopkins University from the Division of Microbiology and Infectious Diseases of the National Institute for Allergy and Infectious Diseases of the National Institutes of Health. The CDRC is an inter-disciplinary consortium of scientists, clinicians and other trained personnel with expertise in TB diagnostics, clinical trials, and international studies. The CDRC is affiliated with four established clinical study sites in TB endemic countries. At these sites, the CDRC will conduct feasibility studies of new diagnostics and provide input back to the technology holder with respect to further development or evaluation. The CDRC will collaborate with other TB research networks and consortia having a common goal of identifying better diagnostic tools and strategies for TB. The Principal Investigator of the CDRC is Dr. Jerrold J. Ellner and the Co-Principal Investigator and Director of Clinical Studies is Dr. Susan Dorman.

The unique mission of the CDRC is to provide data early in the
developmental pipeline on the performance of investigational diagnostics and their potential impact on TB management algorithms in endemic countries. The CDRC will contribute to the science of diagnostics and will inform and advise scientists and manufacturers on further development and refinement of diagnostics that promise to accelerate and improve the accuracy of TB diagnosis and the rapid detection of drug resistance.

Do you know about the UNHLM declaration:

Specializations / Areas of Work

Research and Development

Other Organization Information

Total number of staff in your organization: 26 - 50
Number of full-time staff who are directly involved with TB: 26 - 50
Number of part-time staff who are directly involved with TB: 26 - 50
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: World TB Day
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
Research related to TB Diagnostics.

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Republic of Korea
South Africa
United States of America


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

New Diagnostics:
TB CDRC evaluates promising diagnostics in endemic country settings, among clinics and laboratories experienced in the conduct of clinical evaluation.

TB CDRC works with partners at cost-effectiveness and comparative-effectiveness research of TB diagnostics and algorithms for TB diagnosis.


Declaration of interests:
No potential conflicts of interest.

Application date: July 20, 2010
Last updated: May 22, 2012